Suraksha Diagnostic IPO subscription starts on 29 November 2024 and will close on 3 December 2024. Suraksha Diagnostic plans to raise around INR 846.25 crores via the IPO. The price band is fixed at INR 420 – 441 per share. Suraksha Diagnostic IPO market lot has 34 shares, and the minimum application amount is INR 14,994. The retail quota is 35%, QIB is 50%, and NII is 15%.
Check Suraksha Diagnostic IPO Subscription Status here. The subscription figures are taken from BSE and NSE and are updated at regular intervals. Here you can find Suraksha Diagnostic IPO Subscription Status segregated by days and investor categories.
Suraksha Diagnostic IPO Subscription Status – Live Updates
Shares allotted to anchor investors are not included in these calculations. Similarly, shares allotted to market makers, if any, are not part of these calculations.
Read Also: C2C Advanced Systems IPO allotment on 29 November: What to expect after 125.4X subscription
Suraksha Diagnostic – Business Background
Suraksha Diagnostic offers an extensive array of clinical testing, diagnostic solutions, and medical consultation services. As of 30 June 2024, the company operates through a robust network that includes a central reference laboratory, eight satellite laboratories, and 215 customer touchpoints. This network also encompasses 49 diagnostic centers and 166 primarily franchised sample collection centers, serving regions in West Bengal, Bihar, Assam, and Meghalaya. The central reference laboratory is accredited by the College of American Pathologists, ensuring compliance with stringent quality standards.
The company maintains a diverse portfolio of over 2,300 tests. Its diagnostic offerings include 788 routine pathology tests—covering basic biochemistry and hematology—and 647 specialized tests that encompass advanced biochemistry, histopathology, and molecular pathology. In the field of radiology, Suraksha provides 748 basic and intermediate tests such as X-rays, ultrasonography (USG), and CT scans, along with 104 advanced tests like MRI and specialized CT scans. The facilities are equipped with 24 CT scan machines and 13 MRI machines.
Read Also: Enviro Infra IPO Allotment: Bids Surpass INR 40,000 Crore, Check Your Status
Investor Categories in Suraksha Diagnostic IPO Subscription
The three most important categories of IPO investors defined by SEBI are part of Suraksha Diagnostic IPO.
Qualified Institutional Buyers (QIB) – Examples of QIBs are Foreign Portfolio Investors (FPIs), Scheduled Commercial Banks, Mutual Funds, Venture Capital Funds, Foreign Venture Capital Investors (FVCIs), Alternative Investment Funds (AIFs), Insurance Companies, Provident Funds and Pension Funds with a minimum corpus of INR 250 million.
Generally, 50% of the offer is reserved for QIBs. Some of these are classified as anchor investors which work towards stabilizing an IPO.
Non-Institutional Investor (NII) – These are affluent investors who can invest more than INR 200,000. In other words, these are High Networth Individuals (HNIs). Generally, 15% of the offer is reserved for this category. Bids in the category need to exceed INR 200,000. Typical examples include Category III FPIs, resident Indian individuals, HUFs (in the name of Karta), companies, corporate bodies, eligible NRIs, scientific institutions, societies, and trusts.
The NII category is further divided into two – big and small – the threshold application amount being INR 10,00,000 (INR 10 lakh).
Retail Individual Investor (RII) – This category is purely meant for small investors, whose bid must not exceed INR 200,000 per person. Usually, 35% of total shares are reserved for this category in the case of a company with profitable operations. If the IPO-bound company does not fulfill this criterion, only 10% of shares are reserved for retail investors.
Employee – Shares reserved for company employees are not part of the Net Offer and there may additionally be a discount on offer price to encourage employees to subscribe. Investors in the employee category may also apply under the retail category in an IPO. Therefore, this category of IPO investors has a unique advantage.
Read Also: IPOs with 500% Returns: Explore Best Performing IPOs
Suraksha Diagnostic IPO Subscription Status FAQs
When will the Suraksha Diagnostic IPO subscription start?
Suraksha Diagnostic IPO subscription starts on 29 November and ends on 3 December 2024.
How to subscribe to Suraksha Diagnostic IPO?
You can subscribe to the IPO through ASBA and non-ASBA options. To use ASBA, login to your bank account and apply for the IPO online. Alternatively, you can download the form online or obtain a physical form, then submit the completed form to your broker or bank.
When will Suraksha Diagnostic IPO be listed?
Suraksha Diagnostic IPO will be listed on 6 December 2024, on the BSE and NSE stock exchanges.
